simvastatin has been researched along with Animal Mammary Carcinoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cruz, P; Reyes, F; Torres, CG | 1 |
Olivares, A; Stoore, C; Torres, CG | 1 |
Ali, H; Nazzal, S; Shirode, AB; Sylvester, PW | 1 |
Adamicova, K; Bojkova, B; Kajo, K; Kassayova, M; Kubatka, P; Nosal, V; Orendas, P; Pec, M; Stollarova, N; Vybohova, D; Zihlavnikova, K | 1 |
Sylvester, PW; Wali, VB | 1 |
5 other study(ies) available for simvastatin and Animal Mammary Carcinoma
Article | Year |
---|---|
Simvastatin modulates β-catenin/MDR1 expression on spheres derived from CF41.Mg canine mammary carcinoma cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta Catenin; Cell Line, Tumor; Dog Diseases; Dogs; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Mammary Neoplasms, Animal; Neoplastic Stem Cells; Simvastatin; Spheroids, Cellular | 2018 |
Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dog Diseases; Dogs; Female; Flow Cytometry; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; In Vitro Techniques; Mammary Neoplasms, Animal; Neoplastic Stem Cells; Simvastatin; Spheroids, Cellular | 2015 |
Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles.
Topics: Animals; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Drug Combinations; Drug Stability; Drug Storage; Female; Inhibitory Concentration 50; Lipids; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Simvastatin; Time Factors; Tocotrienols; X-Ray Diffraction | 2010 |
Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Proliferation; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Mammary Neoplasms, Animal; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Simvastatin | 2012 |
Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mammary Neoplasms, Animal; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pravastatin; Proto-Oncogene Proteins c-akt; Simvastatin; Vitamin E | 2007 |